Sign in

CIK 0001745999

  • Large accelerated filer

Beam Therapeutics Inc.

Sign in to watch
Ticker
BEAM
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 857-327-8775
Business address
26 LANDSDOWNE STREET, CAMBRIDGE, MA, 02139
Former names
Beam Therapeutics Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,193,310
in 2 filings, $1.2M under 10b5-1 plans

Net −$1,193,310. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-06-03 Fishman Mark Director Grant or award · Stock Option (Right to Buy) +19,676 19,676
2025-06-04 Fishman Mark Director Grant or award · Stock Option (Right to Buy) +33,662 33,662
2024-06-05 Fishman Mark Director Grant or award · Stock Option (Right to Buy) +23,114 23,114
2023-06-06 Fishman Mark Director Grant or award · Stock Option (Right to Buy) +16,532 16,532
2022-09-01 Fishman Mark Director Grant or award · Stock Option (Right to Buy) +10,391 10,391
2021-06-10 Fishman Mark Director Grant or award · Stock Option (Right to Buy) +6,877 6,877
2020-02-10 Fishman Mark Director Conversion +17,007 17,007
2020-02-10 Fishman Mark Director Conversion · Series A-1 Preferred Stock −15,768 0
2020-02-10 Fishman Mark Director Conversion · Series A-2 Preferred Stock −1,239 0

Page 1 of 1 · 9 trades